Cabozantinib for previously treated advanced differentiated thyroid cancer unsuitable for or refractory to radioactive iodine

Technology appraisal guidance
Reference number: TA928
Published: 01 November 2023

Evidence

Supporting evidence

Evaluation report
Draft guidance consultation committee papers (PDF 9.14 MB)

Published:

01 November 2023
Final draft guidance committee papers (PDF 1.99 MB)

Published:

01 November 2023